Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21555689 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane;   Drug: letrozole;   Procedure: Therapeutic Conventional Surgery
2 Recruiting Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant endocrine therapy;   Drug: Neoadjuvant chemotherapy

Study has passed its completion date and status has not been verified in more than two years.